Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fibroblast growth factor 21 in migraine headache
IRCT20190804044429N3Phase 2Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Apr 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of native FGF21 in migraine, sponsored by Mazandaran University of Medical Sciences. Started Apr 2020; status: completed.
02
Drugs
native FGF21
03
Conditions
migraine
Beyond the preview
Go deeper on IRCT20190804044429N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190804044429N3.